Arcturus Therapeutics (ARCT) Financials: Revenue & Earnings

ARCT price $11.97 +0.74 +6.56%

Ticker
ARCT
Price
$11.97
Change
+0.74 +6.56%
Market cap ?
$340.13M
P/E ?
-3.37
Forward P/E ?
3.81
Dividend yield ?
0.00%
Beta ?
2.48
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
48
Value
60
Quality
34
Growth
50

Stocklytics score rationale: value 60, quality 34, growth 50.

Financials

2016201720182019202020212022202320242025
2038200012998000157530002078900095390001235900020575500015774800013838900067221000

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by…

Fair value

ARCT fair value $68.29. Price $11.97. Price is 82% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 18.97M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 28.42M. Net debt -205.91M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ARCT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.60—8.04M
2026-08-06-0.84-1.002.96M3.11M
2026-05-07-0.95-1.032.06M6.30M
2026-03-03-1.03-0.927.20M15.90M
2025-11-10-0.49-0.8017.15M16.03M
2025-08-11-0.34-0.8928.30M18.83M
2025-05-12-0.52-1.5829.38M23.35M
2025-03-06-1.11-0.3322.77M39.95M
2024-11-07-0.26-0.7038.81M45.92M
2024-08-05-0.64-1.8545.98M34.25M
2024-05-08-1.00-1.1732.60M17.54M
2024-03-07-0.32-1.6928.21M37.86M
2023-11-14-0.61-1.7943.38M41.64M
2023-08-07-1.980.099.56M48.50M
2023-05-091.870.0680.28M37.94M
2023-03-284.430.98160.05M72.68M
2022-11-09-1.33-2.0113.37M4.57M
2022-08-09-0.82-1.8427.09M3.14M
2022-05-09-1.94-1.295.24M7.08M
2022-02-28-1.47-1.775.79M14.75M
2021-11-08-2.05-1.402.44M11.65M
2021-08-09-2.07-1.992.00M2.00M
2021-05-10-2.15-1.162.13M1.47M
2021-03-01-1.25-0.902.24M—
2020-11-09-0.92-0.472.33M1.59M
2020-08-10-0.55-0.532.32M2.32M
2020-05-07-0.67-0.492.65M2.41M
2020-03-11-0.76-0.492.97M2.07M
2019-11-07-0.56-0.243.32M2.13M
2019-08-15-0.07-0.5310.15M91.38M
2019-05-13-0.68-0.444.35M3.71M
2019-03-18-0.08-0.487.58M26.10M
2018-11-07-0.42-0.353.42M4.56M
2018-10-01-0.50-0.342.39M2.42M
2018-05-14-1.08-0.4613.00M2.04M
2018-04-02-0.66—2.37M—
2017-11-09-0.70-2.663.30M—
2017-08-11-0.91-0.943.76M—
2017-05-30-0.91-1.263.84M—
2017-02-15-1.54-1.90——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Special.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2013-01-08$0.062013-01-082013-01-15Special
2013-01-04$0.062013-01-082013-01-15Monthly
2012-12-05$0.06—2012-12-15Monthly
2012-11-06$0.06—2012-11-15Monthly
2012-10-03$0.06—2012-10-15Monthly
2012-09-05$0.06—2012-09-15Monthly
2012-08-06$0.06—2012-08-15Monthly
2012-07-03$0.06—2012-07-15Monthly
2012-06-06$0.06—2012-06-15Monthly
2012-05-04$0.06—2012-05-15Monthly
2012-04-03$0.06—2012-04-15Monthly
2012-03-06$0.02—2012-03-15Monthly

Insider trades

DateInsiderActionSharesPriceValue
2026-06-05HOLMES EDWARD WBuy15.00K$7.30109.50K
2026-06-05FARRELL PETER CBuy15.00K$7.30109.50K
2026-06-05BARLOW JAMES FBuy15.00K$7.30109.50K
2026-06-05Markels JohnBuy15.00K$7.30109.50K
2026-06-05Slaoui MoncefBuy15.00K$7.30109.50K
2026-06-05Marquet MagdaBuy15.00K$7.30109.50K
2026-06-05Marantz Jing L.Buy15.00K$7.30109.50K
2026-05-01MULROY DENNISBuy100.00K$8.63863.00K
2026-05-01MULROY DENNISOther0——
2025-12-17Roberts JosephBuy10.00K$6.5265.20K
2025-12-17Chivukula PadBuy54.00K$6.52352.08K
2025-12-17Payne Joseph EBuy175.00K$6.521.14M
2025-12-17Kurata LanceBuy54.00K$6.52352.08K
2025-12-12Roberts JosephOther0——
2025-12-12Roberts JosephOther0——
2025-12-12Roberts JosephOther1.00K$37.4437.44K
2025-12-12Roberts JosephOther5.00K$14.1270.60K
2025-12-12Roberts JosephOther5.00K$8.0040.00K
2025-12-12Roberts JosephOther6.49K$99.29644.59K
2025-12-12Roberts JosephOther7.00K$34.57241.99K
2025-12-12Roberts JosephOther7.00K$16.92118.44K
2025-12-12Roberts JosephOther9.00K$16.24146.16K
2025-12-12Roberts JosephOther7.50K$28.88216.60K
2025-08-15SASSINE ANDYBuy1.24K$16.5620.50K
2025-08-15SASSINE ANDYSell1.24K$16.5620.50K
2025-06-09FARRELL PETER CBuy15.00K$12.54188.10K
2025-06-09Slaoui MoncefBuy15.00K$12.54188.10K
2025-06-09Marquet MagdaBuy15.00K$12.54188.10K
2025-06-09Markels JohnBuy15.00K$12.54188.10K
2025-06-09Marantz Jing L.Buy15.00K$12.54188.10K
2025-06-09BARLOW JAMES FBuy15.00K$12.54188.10K
2025-06-09HOLMES EDWARD WBuy15.00K$12.54188.10K
2024-12-16Kurata LanceBuy60.00K$16.24974.40K
2024-12-16Payne Joseph EBuy196.00K$16.243.18M
2024-12-16Chivukula PadBuy60.00K$16.24974.40K
2024-12-16SASSINE ANDYBuy60.00K$16.24974.40K
2024-10-15Chivukula PadSell12.00K$20.76249.12K
2024-06-19Slaoui MoncefBuy15.00K$25.96389.40K
2024-06-19Slaoui MoncefBuy14.79K$25.96384.05K
2024-06-19Slaoui MoncefOther0——
2024-06-14Marantz Jing L.Buy15.00K$31.00465.00K
2024-06-14Marantz Jing L.Buy3.13K——
2024-06-14Marantz Jing L.Sell3.13K——
2024-06-14HOLMES EDWARD WBuy15.00K$31.00465.00K
2024-06-14HOLMES EDWARD WBuy3.13K——
2024-06-14HOLMES EDWARD WSell3.13K——
2024-06-14Markels JohnBuy15.00K$31.00465.00K
2024-06-14Markels JohnBuy3.13K——
2024-06-14Markels JohnSell3.13K——
2024-06-14Marquet MagdaBuy15.00K$31.00465.00K
2024-06-14Marquet MagdaBuy3.13K——
2024-06-14Marquet MagdaSell3.13K——
2024-06-14BARLOW JAMES FBuy15.00K$31.00465.00K
2024-06-14BARLOW JAMES FBuy3.13K——
2024-06-14BARLOW JAMES FSell3.13K——
2024-06-14FARRELL PETER CBuy3.13K——
2024-06-14FARRELL PETER CBuy15.00K$31.00465.00K
2024-06-14FARRELL PETER CSell3.13K——
2024-06-12SASSINE ANDYSell50.00K$32.031.60M
2024-06-05Chivukula PadSell114$45.005.13K
2024-06-03Chivukula PadSell26.00K$40.011.04M
2024-03-25Chivukula PadSell17.43K$35.02610.57K
2024-03-19Chivukula PadSell8.56K$35.01299.84K
2023-12-15SASSINE ANDYBuy75.00K$28.882.17M
2023-12-15Chivukula PadBuy125.00K$28.883.61M
2023-12-15Kurata LanceBuy75.00K$28.882.17M
2023-12-15Kummerfeld Keith CBuy30.00K$28.88866.40K
2023-12-15Payne Joseph EBuy200.00K$28.885.78M
2023-11-01Chivukula PadSell5.00K$18.7293.60K
2023-10-02Chivukula PadSell5.00K$25.61128.06K
2023-09-01Chivukula PadSell5.00K$31.45157.26K
2023-08-15SASSINE ANDYBuy1.22K$17.3721.25K
2023-08-01Chivukula PadSell5.00K$34.91174.55K
2023-08-01Markels JohnBuy11.87K$34.92414.47K
2023-08-01Markels JohnBuy3.13K——
2023-08-01FARRELL PETER CBuy11.87K$34.92414.47K
2023-08-01FARRELL PETER CBuy3.13K——
2023-08-01Marantz Jing L.Buy11.87K$34.92414.47K
2023-08-01Marantz Jing L.Buy3.13K——
2023-08-01HOLMES EDWARD WBuy11.87K$34.92414.47K
2023-08-01HOLMES EDWARD WBuy3.13K——
2023-08-01BARLOW JAMES FBuy11.87K$34.92414.47K
2023-08-01BARLOW JAMES FBuy3.13K——
2023-08-01Marquet MagdaBuy11.87K$34.92414.47K
2023-08-01Marquet MagdaBuy3.13K——
2023-07-14Chivukula PadSell25.00K$35.01875.25K
2023-07-14Kummerfeld Keith CSell4.50K$9.0440.68K
2023-07-14Kummerfeld Keith CSell1.03K$14.1214.56K
2023-07-14Kummerfeld Keith CBuy1.03K$14.1214.56K
2023-07-14Kummerfeld Keith CSell1.44K$4.997.17K
2023-07-14Kummerfeld Keith CBuy1.44K$4.997.17K
2023-07-14Kummerfeld Keith CBuy4.50K$9.0440.68K
2023-07-14Kummerfeld Keith CSell6.97K$35.00243.88K
2023-07-03Chivukula PadSell5.00K$28.75143.75K
2023-06-01Chivukula PadSell5.00K$27.16135.80K
2023-05-11Chivukula PadSell7.92K$30.24239.65K
2023-05-10Chivukula PadSell17.07K$30.00512.25K
2023-05-01Chivukula PadSell5.00K$25.93129.65K
2023-04-18Kummerfeld Keith CBuy1.44K$4.997.17K
2023-04-18Kummerfeld Keith CBuy4.50K$9.0440.68K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 140, holders +10 vs prior quarter. Ownership 88.72%.

HolderSharesChangeChange %Value
FEDERATED HERMES, INC.3.30M00.00%22.20M
ARK INVESTMENT MANAGEMENT LLC2.90M132.12K+4.77%19.50M
BLACKROCK, INC.2.61M731+0.03%17.57M
SUMITOMO MITSUI TRUST GROUP, INC.1.96M-325.81K-14.23%13.19M
AMOVA ASSET MANAGEMENT AMERICAS, INC.1.96M-328.48K-14.35%13.14M
VANGUARD CAPITAL MANAGEMENT LLC1.11M7.94K+0.72%7.49M
TWO SIGMA INVESTMENTS, LP1.09M9.35K+0.86%7.33M
VANGUARD PORTFOLIO MANAGEMENT LLC951.58K-26.35K-2.69%6.39M
GEODE CAPITAL MANAGEMENT, LLC693.66K32.73K+4.95%4.66M
AQR CAPITAL MANAGEMENT LLC675.01K513.74K+318.54%4.54M
JACOBS LEVY EQUITY MANAGEMENT, INC647.51K448.78K+225.83%4.35M
STATE STREET CORP569.60K25.73K+4.73%3.83M
UBS GROUP AG490.63K32.35K+7.06%3.30M
D. E. SHAW & CO., INC.392.36K140.32K+55.68%2.64M
EMPIRE LIFE INVESTMENTS INC.366.22K-17.28K-4.50%2.46M
HENNION & WALSH ASSET MANAGEMENT, INC.346.21K66.53K+23.79%2.33M
MILLENNIUM MANAGEMENT LLC337.00K-141.56K-29.58%2.26M
GOLDMAN SACHS GROUP INC309.86K111.18K+55.96%2.08M
BNP PARIBAS FINANCIAL MARKETS261.79K66.93K+34.35%1.76M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC231.63K15.13K+6.99%1.56M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.231.63K231.63KNew1.56M
POINT72 ASSET MANAGEMENT, L.P.231.58K167.74K+262.73%1.56M
DIMENSIONAL FUND ADVISORS LP221.32K-67.03K-23.25%1.49M
HEARTLAND ADVISORS INC219.30K-36.70K-14.34%1.47M
NORTHERN TRUST CORP204.58K-15.04K-6.85%1.37M

Earnings and financials

Arcturus Therapeutics Holdings Inc. (ARCT) trades at $11.97, with a market cap of $340.13M and a trailing P/E of -3.37. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
2038200012998000157530002078900095390001235900020575500015774800013838900067221000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Arcturus Therapeutics (ARCT) Financials: Revenue & Earnings

ARCT$11.97+0.74 +6.56%

$340.13M

Market Cap

-3.37

P/E

3.81

Forward P/E

48

Score

Price History